Associate Director, Clinical Biomarker

BeiGene

12d•$147,100 - $197,100

About The Position

We are seeking an Associate Director of Clinical Biomarker & Translational Medicine for Oncology (Solid Tumor Portfolio, GI franchise) to provide strategic, scientific, and operational leadership across our clinical biomarker initiatives for solid tumor oncology programs. This role is pivotal in driving the development and execution of innovative biomarker strategies that accelerate our clinical trials and pipeline advancement.

Requirements

PhD or MD/PhD in a relevant scientific discipline, with 5+ years’ experience in pharmaceutical or biotechnology settings, focusing on biomarker science in oncology.
Deep expertise in biomarker discovery, clinical assay development, and validation (including proficiency in designing and analyzing biomarker-driven clinical trials).
Strong experience in pre-clinical oncology research and drug discovery.
Demonstrated leadership in translational medicine, with a track record of successful biomarker strategies leading to regulatory submissions, approvals, or high-impact publications.
Experience managing cross-functional and cross-institutional teams.
Excellent communication, reporting, and presentation skills.
Proven ability to thrive in dynamic, fast-paced environments and to mentor junior scientists and project teams.
Strong publication record and/or regulatory contributions in oncology clinical development.
Mandarin language proficiency is required.

Nice To Haves

Fosters Teamwork
Provides and Solicits Honest and Actionable Feedback
Self-Awareness
Acts Inclusively
Demonstrates Initiative
Entrepreneurial Mindset
Continuous Learning
Embraces Change
Results-Oriented
Analytical Thinking/Data Analysis
Financial Excellence
Communicates with Clarity

Responsibilities

Lead global clinical biomarker strategy for solid tumor oncology, in partnership with cross-functional teams, ensuring effective design and implementation of biomarker and companion diagnostic initiatives throughout the drug development continuum.
Oversee biomarker assay development and validation, including scientific input on assay design, proficiency testing, and analytical/clinical validation, ensuring readiness for regulatory and clinical decision points.
Direct the comprehensive analysis and interpretation of biomarker data to inform go/no-go decisions and trial advancement.
Effectively communicate with internal and external stakeholders, translating biomarker data into tangible insights and strategy recommendations.
Serve as scientific leader and subject matter expert, actively contributing to scientific discussions, program strategy, and the advancement of clinical stage projects.
Drive and manage external partnerships with academic institutions, CROs, and industry partners to enhance biomarker discovery and development efforts.
Contribute to regulatory submissions related to biomarker strategies and companion diagnostics.
Champion biomarker-related publications, driving thought leadership and innovation in oncology drug development.